Bernhard Haring1,2,3, Kathleen Hovey4, Mike LaMonte4, Chris Andrews4, Nazmus Saquib5, JoAnn E Manson6, Daichi Shimbo7, Robert Ritch8, Carlos Gustavo De Moraes9, Sylvia Wassertheil-Smoller3. 1. Department of Medicine III, Saarland University, Homburg, Saarland, Germany. 2. Department of Medicine I, University of Würzburg, Würzburg, Bavaria, Germany. 3. Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY. 4. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo-SUNY, Buffalo, NY. 5. College of Medicine, Sulaiman AlRajhi University, Saudi Arabia. 6. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 7. Department of Medicine, Columbia University Irving Medical Center, New York City, NY. 8. Einhorn Clinical Research Center, New York Eye & Ear Infirmary New York, New York City, NY. 9. Department of Ophthalmology, Columbia University Irving Medical Center, New York City, NY.
Abstract
OBJECTIVE: Individuals with elevated systolic blood pressure (BP) or low diastolic BP, whether or not on antihypertensive treatment, may be at higher risk for developing glaucoma. We aimed to investigate BP levels in relation to glaucoma risk in a large cohort of postmenopausal women. METHODS: Prospective follow-up of 101,447 postmenopausal women without prior history of glaucoma enrolled in the Women's Health Initiative Study. BP was measured in-clinic at baseline and after 3 years using standardized procedures. Antihypertensive medication use was determined by drug inventory at baseline and year 3. Women self-reported incident newly diagnosed glaucoma annually. Hazard ratios (HRs) and 95% confidence intervals were estimated using Cox proportional hazards analyses adjusting for demographic, medical history, and lifestyle covariates. RESULTS: During a mean follow-up of 4.7 years, we documented 7,514 glaucoma cases. Among women not on antihypertensive treatment, those with systolic BP ≥ 140 mm Hg or diastolic BP ≥80 mm Hg were not at higher risk of developing glaucoma (HR 0.97, 95% confidence intervals 0.88-1.08 and HR 1.00 [0.93-1.08], respectively), compared with women with a systolic BP < 120 mm Hg or a diastolic BP 60 to <80 mm Hg. Among women on antihypertensive treatment, neither systolic BP ≥ 140 mm Hg nor diastolic BP ≥80 mm Hg was associated with an increased glaucoma risk (HR 0.89 [0.79-1.00] and HR 0.97 [0.90-1.05], respectively). A diastolic BP <60 mm Hg was not associated with a higher risk compared with a diastolic BP 60 to <80 mm Hg. CONCLUSIONS: BP control is not associated with an increased or decreased glaucoma risk in postmenopausal women.
OBJECTIVE: Individuals with elevated systolic blood pressure (BP) or low diastolic BP, whether or not on antihypertensive treatment, may be at higher risk for developing glaucoma. We aimed to investigate BP levels in relation to glaucoma risk in a large cohort of postmenopausal women. METHODS: Prospective follow-up of 101,447 postmenopausal women without prior history of glaucoma enrolled in the Women's Health Initiative Study. BP was measured in-clinic at baseline and after 3 years using standardized procedures. Antihypertensive medication use was determined by drug inventory at baseline and year 3. Women self-reported incident newly diagnosed glaucoma annually. Hazard ratios (HRs) and 95% confidence intervals were estimated using Cox proportional hazards analyses adjusting for demographic, medical history, and lifestyle covariates. RESULTS: During a mean follow-up of 4.7 years, we documented 7,514 glaucoma cases. Among women not on antihypertensive treatment, those with systolic BP ≥ 140 mm Hg or diastolic BP ≥80 mm Hg were not at higher risk of developing glaucoma (HR 0.97, 95% confidence intervals 0.88-1.08 and HR 1.00 [0.93-1.08], respectively), compared with women with a systolic BP < 120 mm Hg or a diastolic BP 60 to <80 mm Hg. Among women on antihypertensive treatment, neither systolic BP ≥ 140 mm Hg nor diastolic BP ≥80 mm Hg was associated with an increased glaucoma risk (HR 0.89 [0.79-1.00] and HR 0.97 [0.90-1.05], respectively). A diastolic BP <60 mm Hg was not associated with a higher risk compared with a diastolic BP 60 to <80 mm Hg. CONCLUSIONS: BP control is not associated with an increased or decreased glaucoma risk in postmenopausal women.
Authors: Fotis Topouzis; Anne L Coleman; Alon Harris; Christian Jonescu-Cuypers; Fei Yu; Leonidas Mavroudis; Eleftherios Anastasopoulos; Theofanis Pappas; Archimidis Koskosas; M Roy Wilson Journal: Am J Ophthalmol Date: 2006-07 Impact factor: 5.258
Authors: Thasarat S Vajaranant; Pauline M Maki; Louis R Pasquale; Anne Lee; Hajwa Kim; Mary N Haan Journal: Am J Ophthalmol Date: 2016-03-03 Impact factor: 5.258
Authors: Jesús D Melgarejo; Joseph H Lee; Michele Petitto; Juan B Yépez; Felipe A Murati; Zhezhen Jin; Carlos A Chávez; Rosa V Pirela; Gustavo E Calmón; Winston Lee; Matthew P Johnson; Luis J Mena; Lama A Al-Aswad; Joseph D Terwilliger; Rando Allikmets; Gladys E Maestre; C Gustavo De Moraes Journal: Ophthalmology Date: 2018-01-06 Impact factor: 12.079
Authors: Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei Journal: Eur Heart J Date: 2013-02-10 Impact factor: 29.983